Research Article

A Retrospective Cohort Study on Rehospitalization following Expanded Criteria Donor Kidney Transplantation

Table 1

Comparing baseline characteristics between SCD and ECD kidney recipients.

nSCDECD
38316

Admit count 180 days before KT, mean (SD)0.0.234 (0.625)0.274 (0.746)
Age, mean (SD)50.196 (12.725)59.049 (9.756)
Total rehosp, median [IQR]1.000 [0.000, 3.000]2.000 [1.000, 4.000]
ESRD cause category, n (%)
FSGS or IgA29 (7.6)9 (5.5)
Membranous or MPGN or lupus31 (8.1)5 (3.0)
Other323 (84.3)150 (91.5)
Induction = thymoglobulin, n (%)311 (83.4)130 (79.8)
MMF, n (%)270 (70.5)123 (75.0)
Sirolimus, n (%)166 (43.3)72 (43.9)
Tacrolimus, n (%)373 (97.4)161 (98.2)
CDC, n (%)61 (15.9)8 (4.9)
DCD, n (%)70 (18.3)12 (7.31)
Years of dialysis before KT, mean (SD)4.747 (4.009)4.092 (3.429)
HCV, n (%)21 (5.5)6 (3.7)
BMI, mean (sd)27.468 (5.854)27.248 (5.300)
CIT, mean (sd)1334.508 (658.539)1382.390 (601.300)
WIT, mean (sd)42.024 (12.696)40.256 (12.979)
Charlson Index, median [IQR]2.000 [2.000, 4.000]2.000 [1.000, 4.000]
Length of post-op stay, median [IQR]7.000 [6.000, 9.000]7.000 [6.000, 10.250]
Diabetes, n (%)No223 (58.2)80 (48.8)
Yes160 (41.8)84 (51.2)
PVD, n (%)No339 (88.5)148 (90.2)
Yes44 (11.5)16 (9.8)
Surgeon, n (%)02 (0.5)0 (0.0)
164 (16.7)29 (17.7)
231 (8.1)12 (7.3)
345 (11.7)18 (11.0)
450 (13.1)33 (20.1)
555 (14.4)22 (13.4)
675 (19.6)28 (17.1)
761 (15.9)22 (13.4)

Format is absolute value (percent within group). ESRD = end-stage renal disease, FSGS = focal segmental glomerulosclerosis, IgA = IgA nephropathy, Mem = membranous nephropathy, MPGN = membranoproliferative glomerulonephritis, Lupus = lupus nephritis, IQR = interquartile range, MMF = mycophenolate mofetil, CDC = Center for Disease Control high-risk kidney, DCD = donated after cardiac death, KT = kidney transplant, HCV = hepatitis C virus, CIT = cold ischemia time, WIT = warm ischemia time, post-op = postoperative, PVD = peripheral vascular disease Each number in the second column represents a specific surgeon who performed the operation.